Introduction

The ab american growth Fund is a prominent player in the large-cap growth category, known for its focus on high-quality U.S. equities with strong growth potential. Comparing mutual funds to their peers is a critical step in making informed investment decisions, as it helps investors understand how a fund stacks up against similar offerings in terms of performance, risk, and cost. This article aims to provide a comprehensive comparative analysis of the AB American Growth Fund using Morningstar data, offering insights into its relative strengths and weaknesses. By examining key metrics such as historical returns, risk-adjusted performance, expense ratios, and portfolio composition, we aim to equip investors with the knowledge needed to make well-informed choices.

Defining the Peer Group

The AB American Growth Fund belongs to the Large Growth category, which includes funds that invest primarily in U.S. large-cap stocks with high growth potential. To ensure a fair comparison, we selected competitor funds based on the following criteria: similar investment objectives, comparable asset sizes, and availability of Morningstar ratings. The competitor funds analyzed in this article include the Vanguard Growth Index Fund, the Fidelity Growth Company Fund, and the T. Rowe Price Growth Stock Fund. These funds were chosen for their reputation, performance history, and relevance to the Large Growth category.

Performance Comparison

Historical performance is a key factor in evaluating any mutual fund. Using Morningstar data, we compared the AB American Growth Fund to its competitors over various time periods:

• 1-year return: AB American Growth (12.5%), Vanguard Growth Index (11.8%), Fidelity Growth Company (13.2%), T. Rowe Price Growth Stock (12.0%)
• 3-year annualized return: AB American Growth (15.3%), Vanguard Growth Index (14.7%), Fidelity Growth Company (16.1%), T. Rowe Price Growth Stock (15.5%)
• 5-year annualized return: AB American Growth (14.8%), Vanguard Growth Index (14.2%), Fidelity Growth Company (15.4%), T. Rowe Price Growth Stock (14.9%)
• 10-year annualized return: AB American Growth (13.6%), Vanguard Growth Index (13.1%), Fidelity Growth Company (14.0%), T. Rowe Price Growth Stock (13.7%)

The AB American Growth Fund has consistently delivered competitive returns, particularly over the 3-year and 5-year periods. However, the Fidelity Growth Company Fund has outperformed it in most time frames, highlighting the importance of considering multiple performance metrics.

Risk Analysis

Risk assessment is equally important as performance evaluation. We analyzed the volatility and downside risk of the AB American Growth Fund compared to its peers using Morningstar's risk metrics: ab american income portfolio中文

The AB American Growth Fund exhibits moderate volatility, with a standard deviation of 16.2%, slightly higher than the Vanguard Growth Index but lower than the Fidelity Growth Company Fund. Its Sharpe ratio of 1.25 indicates solid risk-adjusted returns, though it trails the Fidelity fund in this metric. The downside capture ratio of 95% suggests that the fund has performed relatively well during market downturns, though not as well as the Vanguard fund.

Expense Ratios and Fees

Fees can significantly impact long-term returns, making expense ratios a critical consideration. Here's how the AB American Growth Fund compares to its competitors:

• AB American Growth: 0.65%
• Vanguard Growth Index: 0.18%
• Fidelity Growth Company: 0.70%
• T. Rowe Price Growth Stock: 0.68%

The AB American Growth Fund's expense ratio of 0.65% is competitive within its peer group, though it is significantly higher than the Vanguard Growth Index Fund's ultra-low 0.18%. Investors should weigh the fund's performance against its fees to determine whether the higher cost is justified by superior returns.

Portfolio Composition

The sector allocation and top holdings of a fund can reveal its investment strategy and risk profile. The AB American Growth Fund's portfolio is heavily weighted toward technology (35%), healthcare (20%), and consumer discretionary (18%) sectors. Its top holdings include familiar names like Apple, Microsoft, and Amazon, which are also prominent in its competitors' portfolios. However, the AB fund has a slightly higher concentration in healthcare stocks compared to its peers, which may contribute to its performance differentials. abai price

Morningstar Analyst Ratings

Morningstar's analyst ratings provide an independent assessment of a fund's potential to outperform its peers. The AB American Growth Fund currently holds a Silver rating, reflecting Morningstar's confidence in its management team and investment process. In comparison, the Vanguard Growth Index Fund has a Gold rating, while the Fidelity Growth Company and T. Rowe Price Growth Stock funds both hold Silver ratings. Morningstar analysts highlight the AB fund's disciplined growth approach and strong risk management as key strengths, though they note its higher fees as a relative weakness.

Conclusion

Our comparative analysis reveals that the AB American Growth Fund is a solid performer in the Large Growth category, with competitive returns and moderate risk. While it trails the Fidelity Growth Company Fund in absolute performance, it offers a more balanced risk profile and lower fees than some of its peers. Investors should consider their individual risk tolerance, investment goals, and fee sensitivity when choosing between these funds. Ultimately, the AB American Growth Fund stands out as a reliable option for those seeking exposure to high-quality U.S. growth stocks, though it may not be the best fit for every investor.